Singapore Medical Group acquires stake in local aesthetics clinic, proposes rights issue
SMG plans for mergers and acquisitions, business expansion
Singapore
CATALIST-LISTED Singapore Medical Group (SMG) is acquiring an 85 per cent stake in Pheniks which operates local aesthetics clinic SW1, with plans to expand the brand across the region.
SMG will pay up up to S$6.5 million, with up to S$3 million paid in cash over three years, while the balance sum will be satisfied through the issuance of some 6.05 million new shares at S$0.578 per share.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
US: Wall St opens sharply higher on soft jobs data
HSBC has no plans to dispose of further businesses, chairman says
Glencore-backed group said near deal for Shell Singapore assets
Chinese share of French EV market slumps after incentives curbed
ARA H-Trust Q1 net property income up marginally to US$6.4 million
JPMorgan unveils IndexGPT in next Wall Street bid to tap AI boom